Role of interferon-α in the treatment of primary glomerulonephritis

American Journal of Kidney Diseases

Volumn 33, Issue 6, 1999, Pages 1142-1146

  Al Wakeel, J ^a   Mitwalli, A ^a   Tarif, N ^a   Al Mohaya, S ^a   Malik, G ^a   Khalil, M ^a  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

Cyclophosphamide; Cytokines; Interferon ; Membranous glomerulonephritis; Mesangial glomerulonephritis; Steroids

Indexed keywords

ALPHA INTERFERON; CYCLOPHOSPHAMIDE; PREDNISONE; STEROID;

ADULT; ARTICLE; CASE REPORT; DRUG MECHANISM; FEMALE; HUMAN; IMMUNOTHERAPY; KIDNEY FAILURE; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; NON INSULIN DEPENDENT DIABETES MELLITUS; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0033015927     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(99)70153-8     Document Type: Article

References (27)

1. M Haria P Benfield Interferon α-2a: A review of its pharmacological properties and therapeutic use in the management of viral hepatitis Drugs 50 1995 873 896
2. TM Phillips Interferon-α induces renal dysfunction and injury Curr Opin Nephrol Hypertens 5 1996 380 383
3. F Belardelli I Gressor The neglected role of type I interferon in the T-cell response: Implications for its clinical use Immunol Today 17 1996 369 372
4. H Tilg New insights into the mechanism of interferonalpha: An immunoregulatory and anti-inflammatory cytokine Gastroenterology 112 1997 1017 1021
5. C Niedrau T Heintges T Hausinger Treatment of chronic hepatitis C with α-interferon: An analysis of the literature Hepatogastroenterology 43 1996 1544 1556
6. SN Wong ECL Yu KW Chan Hepatitis B virus associated membranous glomerulonephritis in children—Experience in Hong Kong Clin Nephrol 40 1993 142 147
7. H Yamabe RJ Johnson DR Gretch H Osawa H Inuma T Sasaki M Kaizuka N Tarmura S Tsunoda Y Fujita Membranoproliferative glomerulonephritis associated with hepatitis C virus infection, responsive to interferon-α Am J Kidney Dis 25 1995 67 69
8. RJ Johnson DR Gretch WG Couser CE Alpers J Wilson M Chung J Hart R Wilson Hepatitis C virus–associated glomerulonephritis. Effect of α-interferon therapy Kidney Int 46 1994 170 1704
9. DR Chung WS Yang SB Kim E Yu YH Chung Y Lee JS Park Treatment of hepatitis C virus–associated glomerulonephritis with recombinant human alpha interferon Am J Nephrol 17 1997 112 117
10. D Schlondorff U Dendorfer V Brumberger C Keuneke Limitations of therapeutic approaches to glomerular diseases Kidney Int 48 supp 50 1995 S19 S25
11. MF Growley HA Austin D Scott CH Yarbor EM Vaughn J Muir DT Boumpas JH Klippel JE Balow AD Steinberg Methylprednisolone and cyclophosphamide alone or in combination in patients with lupus nephritis. A randomized controlled trial Ann Intern Med 125 1996 549 557
12. GS Hoffman GS Kerr RY Leaville CW Hallahan RS Lebovics WP Jeanis M Rollem AS Fauci Wegners' granulomatosis: An analysis of 158 patients Ann Intern Med 116 1992 488 498
13. DC Cattran C Greenwood S Ritchie K Bernstein DN Churchill WF Clark PA Morrin S Lavoie A controlled trial of cyclosporine in patients with progressive membranous nephropathy Kidney Int 47 1995 1130 1135
14. AH Mitwalli JS Wakeel SA Mohaya HG Malik H Abu-Aisha OS Hassan M Akhtar Pattern of glomerular disease in Saudi Arabia Am J Kidney Dis 27 1996 797 802
15. DJ O'Donoghue W Lawler LB Hunt EJ Acheson NP Malick IgM-associated primary diffuse mesangial proliferative glomerulonephritis: Natural history and prognostic factors Q J Med 79 1991 333 350
16. A Koyama M Fujisaki M Kobayashi M Igarashi M Narita A glomerular permeability factor produced by human T-cell hybridomas Kidney Int 40 1991 453 460
17. HA Austin TT Anlowvych K Mackay DT Boumpas JE Balow NIH conference: Membranous nephropathy Ann Intern Med 116 1992 672 682
18. K Retmarr J Kienast JV Loo Minimal change glomerulonephritis with reversible proteinuria during interferon-α therapy for chronic myeloid leukemia Am J Hematol 49 1995 355 356
19. D Davies BM Hall Recombinant interferon alpha and hemolytic uremic syndrome: Cause or coincidence Am J Hematol 46 1994 152 153
20. A Tranor T Kuzel E Sameulson Y Kanwar Minimal change glomerulopathy and glomerular visceral epithelial hyperplasia associated with alpha interferon therapy for cutaneous T-cell lymphoma Nephron 67 1994 94 100
21. PF Renault JH Hoofnagle Side effects of alpha interferon Semin Liver Dis 9 1989 273 277
22. EC Borden D Parkinson Interferons: Effectiveness, toxicities, and costs Ann Intern Med 125 1996 614 615
23. M Aikeda S Minota S Kano Regulation of MHC class I expression by inflammatory cytokines in rat mesangial cells Nephron 76 1997 90 95
24. M Magnone JL Holley R Shapiro V Scantelbury J McCauley M Jordan C Vivas T Starzl JP Johnson Interferon-α induced acute allograft rejection Transplantation 59 1995 1068 1070
25. L Rostaing A Modesto E Baron JM Cisterne MH Chabannier D Durand Acute renal failure in kidney transplant patients treated with interferon alpha-2b for chronic hepatitis C Nephron 74 1996 512 516
26. GH Tessh HY Lan RC Atkins PDJ Nikolic Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis Am J Pathol 151 1997 141 150
27. HY Lan DJ Nikolic-Paterson M Zarama JL Vanice RC Atkins Suppression of experimental crescentic glomerulonephritis by interleukin 1-receptor antagonist Kidney Int 43 1993 479 485